NO923749L - Bcrf1-antagonister for behandling av epstein-barr-virusinfeksjoner - Google Patents
Bcrf1-antagonister for behandling av epstein-barr-virusinfeksjonerInfo
- Publication number
- NO923749L NO923749L NO92923749A NO923749A NO923749L NO 923749 L NO923749 L NO 923749L NO 92923749 A NO92923749 A NO 92923749A NO 923749 A NO923749 A NO 923749A NO 923749 L NO923749 L NO 923749L
- Authority
- NO
- Norway
- Prior art keywords
- bcrf1
- treatment
- epstein
- barr virus
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—DNA viruses
- C07K16/085—Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49898590A | 1990-03-26 | 1990-03-26 | |
| PCT/US1991/001812 WO1991014451A1 (en) | 1990-03-26 | 1991-03-22 | Bcrf1 antagonists for treating epstein-barr virus infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO923749D0 NO923749D0 (no) | 1992-09-25 |
| NO923749L true NO923749L (no) | 1992-09-25 |
Family
ID=23983319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO92923749A NO923749L (no) | 1990-03-26 | 1992-09-25 | Bcrf1-antagonister for behandling av epstein-barr-virusinfeksjoner |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5756342A (de) |
| EP (1) | EP0522010B1 (de) |
| JP (1) | JP2509774B2 (de) |
| KR (1) | KR960004856B1 (de) |
| CN (1) | CN1056245A (de) |
| AT (1) | ATE126704T1 (de) |
| AU (1) | AU650013B2 (de) |
| CA (1) | CA2079230C (de) |
| DE (1) | DE69112392T2 (de) |
| DK (1) | DK0522010T3 (de) |
| ES (1) | ES2076526T3 (de) |
| FI (1) | FI924278A7 (de) |
| GR (1) | GR3017920T3 (de) |
| HU (1) | HUT63339A (de) |
| IE (1) | IE70910B1 (de) |
| IL (1) | IL97629A0 (de) |
| MX (1) | MX9203522A (de) |
| MY (1) | MY106163A (de) |
| NO (1) | NO923749L (de) |
| OA (1) | OA09674A (de) |
| PT (1) | PT97108B (de) |
| WO (1) | WO1991014451A1 (de) |
| ZA (1) | ZA912138B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6887096A (en) * | 1996-09-11 | 1998-04-02 | Patrick T. Prendergast | Immune direction therapy |
| CN111574621B (zh) * | 2020-04-30 | 2022-03-29 | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 一种中和eb病毒的单克隆抗体及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4614810A (en) * | 1984-09-24 | 1986-09-30 | Pennwalt Corporation | 4,5-dihydro-4-oxo-2-[(2-trans-phenylcyclopropyl)amino]-3-furancarboxylic acids and derivatives thereof |
| US5231012A (en) * | 1989-06-28 | 1993-07-27 | Schering Corporation | Nucleic acids encoding cytokine synthesis inhibitory factor (interleukin-10) |
-
1991
- 1991-03-21 ZA ZA912138A patent/ZA912138B/xx unknown
- 1991-03-21 IE IE94291A patent/IE70910B1/en not_active IP Right Cessation
- 1991-03-21 IL IL97629A patent/IL97629A0/xx unknown
- 1991-03-21 MY MYPI91000467A patent/MY106163A/en unknown
- 1991-03-22 MX MX9203522A patent/MX9203522A/es unknown
- 1991-03-22 CN CN91101903A patent/CN1056245A/zh active Pending
- 1991-03-22 HU HU923068A patent/HUT63339A/hu unknown
- 1991-03-22 AT AT91907134T patent/ATE126704T1/de not_active IP Right Cessation
- 1991-03-22 CA CA002079230A patent/CA2079230C/en not_active Expired - Fee Related
- 1991-03-22 KR KR1019920702329A patent/KR960004856B1/ko not_active Expired - Fee Related
- 1991-03-22 PT PT97108A patent/PT97108B/pt not_active IP Right Cessation
- 1991-03-22 JP JP3507265A patent/JP2509774B2/ja not_active Expired - Lifetime
- 1991-03-22 DK DK91907134.0T patent/DK0522010T3/da active
- 1991-03-22 EP EP91907134A patent/EP0522010B1/de not_active Expired - Lifetime
- 1991-03-22 AU AU75882/91A patent/AU650013B2/en not_active Ceased
- 1991-03-22 DE DE69112392T patent/DE69112392T2/de not_active Expired - Fee Related
- 1991-03-22 ES ES91907134T patent/ES2076526T3/es not_active Expired - Lifetime
- 1991-03-22 WO PCT/US1991/001812 patent/WO1991014451A1/en not_active Ceased
- 1991-03-22 FI FI924278A patent/FI924278A7/fi not_active Application Discontinuation
-
1992
- 1992-09-25 OA OA60281A patent/OA09674A/en unknown
- 1992-09-25 NO NO92923749A patent/NO923749L/no unknown
-
1995
- 1995-06-05 US US08/461,778 patent/US5756342A/en not_active Expired - Fee Related
- 1995-10-31 GR GR950403026T patent/GR3017920T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE910942A1 (en) | 1991-10-09 |
| WO1991014451A1 (en) | 1991-10-03 |
| ZA912138B (en) | 1991-12-24 |
| EP0522010B1 (de) | 1995-08-23 |
| CA2079230A1 (en) | 1991-09-27 |
| ATE126704T1 (de) | 1995-09-15 |
| DK0522010T3 (da) | 1996-01-15 |
| US5756342A (en) | 1998-05-26 |
| CN1056245A (zh) | 1991-11-20 |
| CA2079230C (en) | 2001-02-13 |
| NO923749D0 (no) | 1992-09-25 |
| AU7588291A (en) | 1991-10-21 |
| KR960004856B1 (ko) | 1996-04-16 |
| AU650013B2 (en) | 1994-06-09 |
| FI924278L (fi) | 1992-09-24 |
| FI924278A0 (fi) | 1992-09-24 |
| OA09674A (en) | 1993-05-15 |
| HUT63339A (en) | 1993-08-30 |
| JP2509774B2 (ja) | 1996-06-26 |
| FI924278A7 (fi) | 1992-09-24 |
| MY106163A (en) | 1995-03-31 |
| JPH05501116A (ja) | 1993-03-04 |
| EP0522010A1 (de) | 1993-01-13 |
| GR3017920T3 (en) | 1996-01-31 |
| DE69112392D1 (de) | 1995-09-28 |
| IE70910B1 (en) | 1997-01-15 |
| PT97108B (pt) | 1998-10-30 |
| PT97108A (pt) | 1991-11-29 |
| MX9203522A (es) | 1992-07-01 |
| IL97629A0 (en) | 1992-06-21 |
| DE69112392T2 (de) | 1996-02-01 |
| ES2076526T3 (es) | 1995-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69609188D1 (de) | Neutralisierende monoklonale antikörper gegen respiratorischen synzytialvirus | |
| ATE163682T1 (de) | Respiratorisches syncytiales virus, impstoffe | |
| ATE175123T1 (de) | Verbesserte immunotherapeutische methode zur verhinderung oder behandlung viraler krankheiten der atemwege | |
| ES2102347T3 (es) | Metodos y composiciones para la utilizacion de polipeptidos env y anticuerpos anti-env de hiv. | |
| ATE429248T1 (de) | Verwendung cd28 spezifischer monoklonaler antikörper zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von virusinfektionen | |
| DK0495008T3 (da) | Vaccinekonjugat til behandling af fuglesygdomme | |
| NO910209D0 (no) | Fremgangsmaate for fremstilling av rekombinante humane anti-cd18 antistoffer. | |
| BR9106159A (pt) | Polipeptideo sintetico,vacina,estojo para detectar hiv ou anticorpos contra hiv,molecula de dna,composicao farmaceutica,anticorpo ou fragmento de ligacao de antigeno do mesmo,processos de terapia ou profilaxia de infeccao hiv,de detectar hiv,de diagnosticar infeccao hiv e para a manufatura de um polipeptideo sintetico,de uma composicao farmaceutica e de um anticorpo ou fragmento de ligacao do mesmo | |
| NO923749L (no) | Bcrf1-antagonister for behandling av epstein-barr-virusinfeksjoner | |
| FI922551A0 (fi) | Foerfarande foer skoetsel av septisk chock. | |
| EP0530216A4 (en) | Administration of monoclonal antibodies against respiratory viruses | |
| DE69126486D1 (de) | Induzierung eines schutzes gegen virale infektionen | |
| ID22942A (id) | Penggunaan antibodi burung | |
| ES2060162T3 (es) | Utilizacion de los anticuerpos monoclonales anti-b2 microglobulina. | |
| FI902814A0 (fi) | Proteiner, vaccin och nukleinsyror. | |
| JPH01131126A (ja) | 抗ウィルス薬としての抗ウィルスネオ抗原抗体及びそれにより誘導された抗イデオタイプ抗体 |